Simple Summary Like in solid cancers, the process of dissemination is a critical feature of
disease progression in the blood cancer multiple myeloma. At diagnosis, myeloma patients …

Multiple myeloma (MM) is the second most common haematological malignancy and is an
incurable disease of neoplastic plasma cells (PC). Newly diagnosed MM patients currently …

Background The incidence of multiple myeloma (MM), a type of blood cancer affecting
monoclonal plasma cells, is rising. Although new drugs and therapies have improved patient …

Simple Summary New treatments have made a big difference in helping people with
multiple myeloma (MM) live longer. In fact, survival rates have almost doubled compared …

Background Hypoxia is a potent molecular signal for cellular metabolism, mitochondrial
function, and migration. Conditions of low oxygen tension trigger regulatory cascades …

This study explores the role of digital financial inclusion in mitigating poverty and bolstering
economic growth, with a special focus on developing nations during the COVID-19 era …

Immune response against malaria and the clearance of Plasmodium parasite relies on
germinal-center-derived B cell responses that are temporally and histologically layered …

In most instances, multiple myeloma (MM) plasma cells (PCs) are reliant on factors made by
cells of the bone marrow (BM) stroma for their survival and growth. To date, the nature and …

The emergence of new molecular targeting agents has improved the prognosis of patients
with multiple myeloma (MM). However, MM remains incurable because MM stem cells are …

The protein SAMSN1 was recently identified as a putative tumor suppressor in multiple
myeloma, with re‐expression of Samsn1 in the 5TGM1/KaLwRij murine model of myeloma …